Dental News - Danaher announces new dental company Envista Holdings Corporation

Danaher Corporation

Fri. 28. June 2019

save

WASHINGTON, US: Danaher Corporation has announced that Envista Holdings Corporation will be the name of the separate company it is to take public via an initial public offering in the second half of 2019. Envista will be comprised of three operating companies within Danaher's Dental segment: Nobel Biocare Systems, KaVo Kerr, and Ormco, all of which have significant positions in dental implants, equipment and orthodontics.

Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets. With more than 20 operating companies, Danaher's globally diverse team of approximately 71,000 associates is united by a common culture and operating system, the Danaher Business System.

Envista will be led by Amir Aghdaei, who will become President and Chief Executive Officer. Mr. Aghdaei currently serves as Danaher Group Executive with responsibility for the Dental segment. Mr. Aghdaei stated, "Envista's culture will be built on four core values: 'Better Choices, Better Outcomes,' 'Relationships Built on Trust,' 'Innovation in Action,' and 'Continuous Improvement as a Competitive Advantage.' Our Danaher heritage helped us shape these values and serves as a strong foundation for our business.”

Envista will employ 12,000 people worldwide and intends to apply to list its common stock on the New York Stock Exchange. The stock symbol will be NVST. For more info, visit the company's website.

One thought on “Danaher announces new dental company Envista Holdings Corporation”

KT huang says:

September 19, 2019 at 7:56 pm

Great article

To post a reply please login or register

Envista Holdings seeks new CEO

BREA, Calif., US: Envista Holdings, the company behind leading dental brands such as Nobel Biocare, Ormco, DEXIS and Kerr, has begun the process of finding ...

Danaher completes separation from Envista

BREA, Calif., U.S.: Envista Holdings has announced that it is no longer bound to parent company Danaher. A successful exchange offering that closed on Dec. ...

GC Holding strengthens corporate governance and announces new CEO

LUCERNE, Switzerland: GC Holding has recently announced the appointment of Dr Per Falk as CEO of the company, effective from 1 October. In April, GC ...

Danaher to spin off dental business into independent company

WASHINGTON, U.S.: Danaher, a global science and technology conglomerate operating in the field of healthcare, among others, has announced its intention to ...

Danaher to offer its shareholders an Envista stock swap

WASHINGTON, U.S.: Danaher Corp. has announced an exchange offer through which its shareholders will have the opportunity to swap their Danaher stock for the...

Envista announces rebranding of imaging business

BREA, Calif., US: Having divested its KaVo treatment unit and instrument business, Envista announced last week that its imaging segment will now be ...

Envista announces expansion of leadership team

BREA, Calif., US: Envista Holdings, a dental equipment and supplies manufacturing company, has recently announced the expansion of its leadership team. The ...

Danaher’s new dental arm Envista takes flight

NEW YORK, USA: Danaher Corp. has successfully spun off its dental businesses into the company Envista Holdings in a successful public share offering that ...

Envista announces 2020 Nobel Biocare Global Symposium

BREA, Calif., U.S.: Envista is proud to announce the 2020 Nobel Biocare Global Symposium, to be held in Las Vegas from April 16 to 18. Empowered by a ...

Swiss dental company vVARDIS secures new investment to expand Curodont rollout

ZUG, Switzerland: Swiss manufacturer vVARDIS has raised an additional US$50 million (€43 million*) in funding from global healthcare investor OrbiMed, ...

Education

Live webinar
Mon. 15 September 2025
1:00 pm EST (New York)